Solomon Rotimi, PhD
@solomonrotimi.bsky.social
Scientist | Cancer Scientist | Clinical Biochemist | African Cancer Genomics Expert | Fulbrighter
Reposted by Solomon Rotimi, PhD
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening.
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients - Abimbola F. Onyia, Paul Jibrin, Temitope Olatunji-Agunbiade, Ademola Oyekan, AbdulRazzaq Lawal, Adewumi Alabi, Antho...
Background Breast cancer remains a leading cause of mortality among Nigerian women, with triple-negative breast cancer (TNBC) being particularly prevalent. Vari...
bit.ly
April 24, 2025 at 4:34 PM
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening.
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
Reposted by Solomon Rotimi, PhD
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening.
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
April 24, 2025 at 4:32 PM
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening.
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
EXCITING ANNOUNCEMENT
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
April 1, 2025 at 9:45 PM
EXCITING ANNOUNCEMENT
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity